Кардиоваскулярный риск у больных анкилозирующим спондилитом: роль системного воспаления и дисфункции эндотелия

Д А Поддубный, Andrey P. Rebrov · Рациональная фармакотерапия в кардиологии · 2008

Aim. To investigate the role of systemic inflammation and endothelial dysfunction as factors of cardiovascular risk in patients with ankylosing spondylitis. Material and Methods. 100 patients with ankylosing spondylitis were included into the study. Screening for arterial hypertension (HT) and conventional cardiovascular risk factors (smoking, hyperand dislipoproteinemia, body overweight, heredity and diabetes mellitus) was performed in all patients. 10-year coronary disease risk (Framingham scale) and 10-year risk of fatal cardiovascular event (SCORE scale) was calculated. Additionally the follows cardiovascular risk factors were assessed: C-reactive protein level (CRP), fibrinogen level, platelet count, antithrombin III activity, plasma fibrinolytic activity, von Willebrand factor (vWF) activity, circulating endothelial cells (CEC) count. Besides, endothelial function was evaluated by Doppler-ultrasonography of brachial artery in tests with reactive (endothelium-dependent or flow-mediated dilation) and nitroglycerine (endothelium-independent dilation) hyperemia. 30 healthy patients were included into control group and were comparable with patients of studied group on sex and age. Results. 10-year coronary disease risk in patients with ankylosing spondylitis was significantly lower than this in patients of control group 4.0%(3,0;7,5)vs5.0%(3,0; 11,0), respectively (p

Cited by 0 works.

Authors